A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and Delta-lineage products since the passage of the 2018 Farm Bill.
Hebrew University Professor Raphael Mechoulam, considered the “father of cannabis research,” has died in Israel.
Delta-8 THC products sold in Kentucky would be restricted to buyers 21 and older and would have to comply with testing and labeling requirements under a bill sailing through the state Legislature.
Medical groups in Virginia are asking the governor to sign a bill as written that adds new restrictions to hemp-derived products in the state.
The Virginia Cannabis Association (VCA) wants the state’s recently passed delta-8 THC bill to be amended because it is too restrictive and could hurt the local hemp industry.
Virginia lawmakers approved tough new restrictions on products containing the controversial hemp-derived cannabinoid delta-8 THC.
Nalu Bio, a producer of synthetic cannabinoids, said it raised $12 million in a Series A funding round led by Intrinsic Capital Partners, a Pennsylvania-based investment firm focused on life science and technology businesses in the legal marijuana and hemp industries.
